Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Novavax, Inc.
  6. Consensus
    NVAX   US6700024010

NOVAVAX, INC.

(NVAX)
  Report
Real-time Estimate Cboe BZX  -  03:27:08 2023-02-06 pm EST
11.05 USD   -1.65%
01/26FDA advisers back the same COVID vaccine for initial shots, boosters
RE
01/26Novavax needs 6 months to produce annual COVID shots that match new variants
RE
01/25Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)
PR
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Evolution of the average Target Price on NOVAVAX, INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) NOVAVAX, INC.
Analyst Recommendations on NOVAVAX, INC.
01/09B. Riley Lowers Novavax's Price Target to $37 From $74, Keeps Buy Rating
MT
2022B. Riley Lowers Novavax's Price Target to $74 From $83, Keeps Buy Rating
MT
2022B. Riley Lowers Novavax's PT to $83 From $126 to Reflect Current Realities of COVID Booste..
MT
2022JPMorgan Downgrades Novavax to Underweight from Neutral, Adjusts Price Target to $27 from ..
MT
2022B. Riley Securities Lowers Novavax's Price Target to $126 from $171 After Lower-than-Expec..
MT
2022Cowen Lowers Novavax's Price Target to $110 From $150, Maintains Outperform Rating
MT
2022B. Riley Lowers Novavax's PT to $171 from $181, Says Volatility to Shares Largely Attribut..
MT
More recommendations
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Last Close Price 11,23 $
Average target price 55,33 $
Spread / Average Target 393%
High Price Target 110,00 $
Spread / Highest target 880%
Low Price Target 13,00 $
Spread / Lowest Target 15,8%
Consensus detail
Consensus revision (last 18 months)